AIM
ENZY

Acrospire Investment Management’s Enzymotec Ltd ENZY Stock Holding History

Acrospire Investment Management’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-9,511
Closed -$80K – 2306
2016
Q2 		$80K Buy
9,511
+6,726
+242% +$55.7K 0.06% 663
2016
Q1 		$25K Buy
+2,785
New +$24.3K 0.02% 1437

Other funds holding ENZY

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Acrospire Investment Management's ENZY Position: Q3 2016 in Review

Acrospire Investment Management sold out of Enzymotec Ltd (ENZY) in Q3 2016, closing a stake of 9,511 shares — an estimated $80K sold.

Acrospire Investment Management first reported a position in ENZY in Q1 2016 and held it in 2 quarters. The position peaked at $80K in Q2 2016. 34 funds tracked by Wall St. Rank hold ENZY as of Q3 2016.

  • Acrospire Investment Management reported no remaining Enzymotec Ltd position as of Q3 2016 after selling out during the quarter.
  • Acrospire Investment Management sold 9,511 Enzymotec Ltd shares in Q3 2016, an estimated $80K.
  • Acrospire Investment Management first reported a position in Enzymotec Ltd in Q1 2016 and held it in 2 quarters.
  • Acrospire Investment Management's Enzymotec Ltd position peaked at $80K in Q2 2016.
  • 34 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q3 2016.

Based on Acrospire Investment Management's 13F filing for Q3 2016, filed 10 Nov 2016.